Elke Dickes Selected Research

Biomarkers (Surrogate Marker)

1/2015

Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elke Dickes Research Topics

Disease

7	Neoplasms (Cancer) 01/2023 - 03/2013
4	Melanoma (Melanoma, Malignant) 01/2023 - 12/2013
1	Breast Neoplasms (Breast Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

3	MicroRNAs (MicroRNA)IBA 01/2023 - 03/2013
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2013
2	AntigensIBA 01/2023 - 01/2015
2	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2017
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 01/2017
1	LuciferasesIBA 01/2023
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 12/2022
1	IonsIBA 12/2022
1	VaccinesIBA 12/2022
1	CarbonIBA 12/2022
1	Peptides (Polypeptides)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Enhancer of Zeste Homolog 2 ProteinIBA 12/2013

Therapy/Procedure

1	Therapeutics 01/2023
1	Radiotherapy 12/2022
1	Radioimmunotherapy 12/2022
1	Subcutaneous Injections 12/2022